Skip to main navigation
Skip to main content

Utility Menu

  • Investors
  • Newsroom
  • Contact Us

Regional Navigation

  • Global Sites
    Global Sites
    • Brazil
      Brazil
      • Portugues
    • France
      France
      • Français
    • Germany
      Germany
      • Deutsch
    • Italy
      Italy
      • Italiano
    • Japan
      Japan
      • Japanese
    • Switzerland
      Switzerland
      • Deutsch
      • English
      • Français
      • Italiano
    • UK
      UK
      • English
    • United States
      United States
      • English
Sarepta Corporate Rebuild

Sarepta Corporate Rebuild

Utility Menu

  • Investors
  • Newsroom
  • Contact Us

Regional Navigation

  • Global Sites
    Global Sites
    • Brazil
      Brazil
      • Portugues
    • France
      France
      • Français
    • Germany
      Germany
      • Deutsch
    • Italy
      Italy
      • Italiano
    • Japan
      Japan
      • Japanese
    • Switzerland
      Switzerland
      • Deutsch
      • English
      • Français
      • Italiano
    • UK
      UK
      • English
    • United States
      United States
      • English
Home

Main navigation

  • Our Disease Areas
    • Duchenne muscular dystrophy
    • Limb-girdle Muscular Dystrophy
    • Mucopolysaccharidosis Type IIIA
    • Charcot-Marie-Tooth Disease
  • Our Science
    • Gene Therapy Engine
    • RNA Platform
    • Gene Editing
    • Manufacturing
  • Our Products & Pipeline
    • Products
    • Pipeline
    • Clinical Trials
    • Treatment Access
  • About Us
    • Leadership
    • Patient Advocacy
    • Grants & Giving
    • Global Locations
    • Contact Us
  • Join Us
    • Find An Opportunity

Social Links

  • Twitter
  • LinkedIn
  • Instagram
  • Facebook

Stock Quote

  • Home
  • Investor Relations
  • Stock Information
  • Stock Quote

IR Menu

IR Home
Press Releases
Events & Presentations
Corporate Governance
Stock Information
SEC Filings
Analyst Coverage
Information Request
FAQs

Tertiary Nav - Stock Information

  • Stock Quote
  • Stock Chart
  • Historical Price Lookup
  • Investment Calculator

Stock Quote

Change
Volume
Today's Open
Previous Close
Today's High
Today's Low
52 Week High
52 Week Low

 

Copyright West LLC. Minimum 15 minutes delayed.

 

 

Toolkit

Print Page | Email Alerts | RSS Feeds | Contacts

Follow Us On Social

  • Twitter
  • LinkedIn
  • Instagram
  • Facebook

Main navigation

  • Our Disease Areas
    • Duchenne muscular dystrophy
    • Limb-girdle Muscular Dystrophy
    • Mucopolysaccharidosis Type IIIA
    • Charcot-Marie-Tooth Disease
  • Our Science
    • Gene Therapy Engine
    • RNA Platform
    • Gene Editing
    • Manufacturing
  • Our Products & Pipeline
    • Products
    • Pipeline
    • Clinical Trials
    • Treatment Access
  • About Us
    • Leadership
    • Patient Advocacy
    • Grants & Giving
    • Global Locations
    • Contact Us
  • Join Us
    • Find An Opportunity

© Sarepta Therapeutics All rights reserved.

02. Footer Utility Nav

  • Privacy Policy
  • Terms of Use